William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.

Equity Research
William Blair research analyst Matt Phipps was quoted in Barron’s following the announcement of a new Medicare drug pricing structure by the Biden administration.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of Vertiv Holdings Co. (VRT $130.87), a global leader in the manufacturing, design, and servicing of critical digital infrastructure for data centers, communication networks, and commercial and industrial end-markets.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures